Viewing StudyNCT04043845

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 1:31 PM
Last Modification Date: 2024-10-26 @ 1:15 PM
Study NCT ID: NCT04043845
Status: WITHDRAWN
Last Update Posted: 2020-02-05
First Post: 2019-07-31
Brief Title: ERK 12 Signaling in Ibrutinib Resistant B-cell Malignancies
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Marginal Zone Lymphoma
Chronic Lymphocytic Leukemia
Waldenstrom Macroglobulinemia
Mantle Cell Lymphoma
Keywords:
Name View
LY3214996 View
Chronic Lymphocytic Leukemia View
Waldenstrom Macroglobulinemia View
Mantle Cell Lymphoma View
Marginal Zone Lymphoma View
CLL View
WM View
MCL View
MZL View
ERK View
Ibrutinib View
BTKCys481 View
PLCG2 View
PLCĪ³2 View